Pharmaceutical Profiling Case Study in Disruption
Edward H. Kerns · ACS Medicinal Chemistry Letters · 2013
ADVERTISEMENT RETURN TO ISSUEPREVViewpointNEXTPharmaceutical Profiling Case Study in DisruptionEdward H. Kerns*View Author Information National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 9th Floor, 6701 Democracy Boulevard, MSC 4874, Bethesda, Maryland 20892-4874, United States*Tel: 301-827-9211. E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2013, 4, 2, 150–152Publication Date (Web):January 7, 2013Publication History Published online7 January 2013Published inissue 14 February 2013https://pubs.acs.org/doi/10.1021/ml300448ghttps://doi.org/10.1021/ml300448geditorialACS PublicationsCopyright © This article not subject to U.S. Copyright. Published 2013 by the American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views2822Altmetric-Citations2LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (425 KB) Get e-AlertscloseSUBJECTS:Assays,Chemical structure,Optimization,Pharmaceuticals,Solubility Get e-Alerts